Sham Innovation Sante is an innovation capital vehicle controlled
Business Model: B2B
Revenue: $37.7M
Employees: 201-500
Address: 18 rue Edouard Rochet
City: Lyon
State: rhône alpes
Zip: 69372
Country: FR
Sham Innovation Sante is an innovation capital vehicle controlled and held by Sham, a mutual insurer specialized in risk management for health care, social welfare and community health organizations. Advised by Turenne Capital, Sham Innovation Sante&s;s mission is to support innovative businesses in the health care sector through the growth and development phases of their life cycle.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2018 | HalioDx | Series B | 22.5M |
6/2012 | Amolyt Pharma | Venture Round | 4.1M |
3/2015 | Amolyt Pharma | Venture Round | 1.9M |
3/2022 | Cairdac | Series A | 0 |
5/2022 | Germitec SAS | Venture Round | 0 |
9/2021 | Amolyt Pharma | Series B | 0 |
7/2021 | Coave Therapeutics | Series B | 0 |
4/2021 | Mablink Bioscience | Seed Round | 0 |
12/2018 | CarThera | Series B | 0 |
8/2021 | Keenturtle | Venture Round | 0 |
7/2019 | Amolyt Pharma | Series A | 0 |
5/2022 | Therapixel | Series B | 0 |
11/2017 | Coave Therapeutics | Series B | 22M |
5/2022 | Therapixel | Series B | 0 |
9/2009 | Amolyt Pharma | Venture Round | 4.3M |
7/2018 | Antabio | Series A | 6.1M |
11/2020 | AbolerIS Pharma | Seed Round | 0 |
5/2022 | Therapixel | Series B | 0 |
5/2022 | Germitec SAS | Venture Round | 0 |
3/2022 | Cairdac | Series A | 0 |
9/2021 | Amolyt Pharma | Series B | 0 |
8/2021 | Keenturtle | Venture Round | 0 |
7/2021 | Coave Therapeutics | Series B | 0 |
4/2021 | Mablink Bioscience | Seed Round | 0 |
11/2020 | AbolerIS Pharma | Seed Round | 0 |
7/2019 | Amolyt Pharma | Series A | 0 |
12/2018 | CarThera | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|